HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach.

AbstractBACKGROUND AND AIMS:
Endoscopic submucosal dissection (ESD) can remove early stage GI tumors of various sizes en bloc; however, success requires reducing the relatively high postprocedure bleeding rate. The aim of this study was to assess the safety and efficacy of a novel, fully synthetic, and self-assembled peptide solution that functions as an extracellular matrix scaffold material to facilitate reconstruction of normal tissues in ESD-induced ulcers.
METHODS:
Consecutive patients who underwent gastric ESD were prospectively enrolled. Immediately after the resection, the solution was applied to the site with a catheter. Gastric ulcers were evaluated by endoscopy and classified as active, healing, or scarring stages at weeks 1, 4, and 8 after ESD.
RESULTS:
Forty-seven patients with 53 lesions, including 14 (29.8%) previously on antithrombotic therapy and 2 (4.3%) requiring heparin bridge therapy, were analyzed; 2 patients were excluded, 1 with perforations and 1 with persistent coagulopathy. The mean size of the en bloc resected specimens was 36.5 ± 11.3 mm. The rate of post-ESD bleeding was 2.0% (1/51; 95% CI, 0.03-10.3). Transitional rate to the healing stage of ESD-induced ulcers at week 1 was 96% (49/51). Subsequent endoscopies demonstrated the scarring stage in 19% (9/48) and 98% (41/42) at weeks 4 and 8, respectively. No adverse effects related to this solution occurred.
CONCLUSIONS:
The use of this novel peptide solution may potentially aid in reducing the delayed bleeding rate by promoting mucosal regeneration and speed of ulcer healing after large endoscopic resections in the stomach. Further studies, particularly randomized controlled studies, are needed to fully evaluate its efficacy.
CLINICAL TRIAL REGISTRATION NUMBER:
000011548.).
AuthorsToshio Uraoka, Yasutoshi Ochiai, Ai Fujimoto, Osamu Goto, Yoshiro Kawahara, Naoya Kobayashi, Takanori Kanai, Sachiko Matsuda, Yuko Kitagawa, Naohisa Yahagi
JournalGastrointestinal endoscopy (Gastrointest Endosc) Vol. 83 Issue 6 Pg. 1259-64 (Jun 2016) ISSN: 1097-6779 [Electronic] United States
PMID26608126 (Publication Type: Journal Article)
CopyrightCopyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Anticoagulants
  • Peptides
  • RADA16-I
Topics
  • Aged
  • Aged, 80 and over
  • Anticoagulants (therapeutic use)
  • Endoscopic Mucosal Resection (adverse effects)
  • Female
  • Gastrointestinal Hemorrhage (epidemiology)
  • Gastroscopy
  • Humans
  • Male
  • Middle Aged
  • Peptides (therapeutic use)
  • Postoperative Hemorrhage (epidemiology)
  • Prospective Studies
  • Stomach Neoplasms (pathology, surgery)
  • Stomach Ulcer (drug therapy, etiology)
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: